Global miRNA Sequencing and Assay Market is Estimated to Value Over USD 330 Million by 2026 End

  • 19 Aug 2019

Global miRNA Sequencing and Assay Market is estimated to value over USD 330 million by 2026 end and register CAGR of over 10.8% during the forecast period 2019 to 2026. 

Genomics is gaining recognition as a mainstream medicine owing to its capability of identifying diseases and providing genetic study-based therapies. This has increased demand for customised medicines which needs a molecular-level understanding of diseases. Therefore, the global miRNA sequencing and assay market shall gain significant traction over the forecast period.

Increasing research on genomics coupled with massive financial backup being provided for this sector is the major driving factors of the market. Decreasing sequencing costs is another factor responsible for the miRNA sequencing and assay market growth. Furthermore, rising demand for target-oriented therapies increases the demand for assay and sequencing thus bolstering the market. Moreover, increasing prevalence of cancer and complexities in the treatment and diagnosis of certain cancer types is anticipated to drive the global market in upcoming years. Nonetheless, rising patient awareness on precision medicine and advancements in genomics are projected to propel the miRNA sequencing and assay market growth further over the forecast period.

However, a lack of skilled professionals can hamper market growth significantly.

Sequencing Consumables Segment is Expected to Witness Significant Market Growth

 The sequencing consumables segment accounted for the largest market share in 2018 and it is expected to witness similar growth trends during the forecast period. This growth can be attributed to the rising adoption of small RNA sequencing along with an increasing demand for consumables.

Academic and research institutes held the largest market share in 2018 and it is expected that this segment will showcase similar market growth during the forecast period. Availability of grants for conducting research and increasing emphasis on key market players on providing miRNA sequencing serviced and products for research applications.

North America is predicted to showcase significant market growth during the forecast period owing to increasing investments in sequencing development, growing research activities in RNA biology and genomics. Furthermore, high-output techniques for analysing miRNA assays and sequencing has boosted the market growth.

Key market players include Thermo Fisher Scientific, Illumina, QIAGEN, Takara Bio and NEB

Global miRNA Sequencing and Assay Market Segmentation:

By Product

·     Sequencing Consumables

·     Library Preparation Kits

By Technology

·     Sequencing by Synthesis

·     Ion Semiconductor Sequencing

·     Sequencing by Oligonucleotide Ligation and Detection

·     Nanopore Sequencing

By End User

·     Research and Academic Institutes

·     Contract Research Organizations

By Region

·     North America

·     Europe

·     Asia Pacific

·     Middle East & Africa

·     Rest of the World

Competitive Landscape:

·     Tier 1 players- established companies in the market with a major market share 

·     Tier 2 players 

·     Emerging players which are growing rapidly 

·     New Entrants

 FutureWise Key Takeaways:

•   Growth prospects

•   SWOT analysis

•   Key trends

•   Key data-points affecting market growth

Objectives of the Study:

·     To provide with an exhaustive analysis on the miRNA sequencing and assay market by product, by technology, by end user and by region

·     To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

·     To evaluate and forecast micro-markets and the overall market

·     To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Middle East & Africa and rest of the world

·     To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

·     Profiling of companies to evaluate their market shares, strategies, financials and core competencies


Get unlimited analyst support and customise this study further to your requirements, contact